Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Molecules (Basel, Switzerland)
|
June 19, 2019
Do We Need Anti-Prion Compounds to Treat Alzheimer's Disease?
Dieter Willbold, Janine Kutzsche
ACS Chemical Neuroscience
|
November 12, 2019
Toward the Mode of Action of the Clinical Stage All-d-Enantiomeric Peptide RD2 on Aβ42 Aggregation
Tao Zhang, Ian Gering, Janine Kutzsche, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 17, 2017
Surprisingly high stability of the Aβ oligomer eliminating all-d-enantiomeric peptide D3 in media simulating the route of orally administered drugs
Anne Elfgen, Beatrix Santiago-Schübel, Lothar Gremer, et al.
Neurochemistry International
|
October 17, 2022
Development of an α-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy
Marc Sevenich, Dominik Honold, Antje Willuweit, et al.
Biomedicines
|
May 16, 2023
Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival
Katharina Wintz, Julia Post, Karl-Josef Langen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Dieter Willbold, Janine Kutzsche, Nicoleta Carmen Cosma, et al.
Biochemistry
|
January 14, 2026
The Proteome of Human Amyloid Beta Oligomers
Bettina Kass, Gereon Poschmann, Fatih Demir, et al.
International Journal of Molecular Sciences
|
July 2, 2021
In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer's Disease
Sarah Schemmert, Luana Cristina Camargo, Dominik Honold, et al.
Neurobiology of Disease
|
April 15, 2026
Elucidation of the influence of the Ca<sub>V</sub>2.2 calcium channel on ALS disease progression in the SOD1*G93A mouse model
Katharina Wintz, Paul Luca Lechtape, Jannes Klenzendorf, et al.
Cell Reports. Medicine
|
May 18, 2022
Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo
Bettina Kass, Sarah Schemmert, Christian Zafiu, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Molecules (Basel, Switzerland)
|
June 19, 2019
Do We Need Anti-Prion Compounds to Treat Alzheimer's Disease?
Dieter Willbold, Janine Kutzsche
ACS Chemical Neuroscience
|
November 12, 2019
Toward the Mode of Action of the Clinical Stage All-d-Enantiomeric Peptide RD2 on Aβ42 Aggregation
Tao Zhang, Ian Gering, Janine Kutzsche, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 17, 2017
Surprisingly high stability of the Aβ oligomer eliminating all-d-enantiomeric peptide D3 in media simulating the route of orally administered drugs
Anne Elfgen, Beatrix Santiago-Schübel, Lothar Gremer, et al.
Neurochemistry International
|
October 17, 2022
Development of an α-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy
Marc Sevenich, Dominik Honold, Antje Willuweit, et al.
Biomedicines
|
May 16, 2023
Oral Treatment with d-RD2RD2 Impedes Early Disease Mechanisms in SOD1*G93A Transgenic Mice but Does Not Prolong Survival
Katharina Wintz, Julia Post, Karl-Josef Langen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Dieter Willbold, Janine Kutzsche, Nicoleta Carmen Cosma, et al.
Biochemistry
|
January 14, 2026
The Proteome of Human Amyloid Beta Oligomers
Bettina Kass, Gereon Poschmann, Fatih Demir, et al.
International Journal of Molecular Sciences
|
July 2, 2021
In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer's Disease
Sarah Schemmert, Luana Cristina Camargo, Dominik Honold, et al.
Neurobiology of Disease
|
April 15, 2026
Elucidation of the influence of the Ca<sub>V</sub>2.2 calcium channel on ALS disease progression in the SOD1*G93A mouse model
Katharina Wintz, Paul Luca Lechtape, Jannes Klenzendorf, et al.
Cell Reports. Medicine
|
May 18, 2022
Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo
Bettina Kass, Sarah Schemmert, Christian Zafiu, et al.
Page
of 5